Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
The Lancet. Global Health
|
April 15, 2021
Estimating and mitigating the risk of COVID-19 epidemic rebound associated with reopening of international borders in Vietnam: a modelling study
Quang D Pham, Robyn M Stuart, Thuong V Nguyen, et al.
Plos One
|
October 4, 2017
Getting it right when budgets are tight: Using optimal expansion pathways to prioritize responses to concentrated and mixed HIV epidemics
Robyn M Stuart, Cliff C Kerr, Hassan Haghparast-Bidgoli, et al.
The Lancet. HIV
|
March 16, 2018
The global Optima HIV allocative efficiency model: targeting resources in efforts to end AIDS
Sherrie L Kelly, Rowan Martin-Hughes, Robyn M Stuart, et al.
Plos Computational Biology
|
July 26, 2021
Covasim: An agent-based model of COVID-19 dynamics and interventions
Cliff C Kerr, Robyn M Stuart, Dina Mistry, et al.
Plos Computational Biology
|
September 27, 2021
Optima TB: A tool to help optimally allocate tuberculosis spending
Lara Goscé, Gerard J Abou Jaoude, David J Kedziora, et al.
Journal of the International AIDS Society
|
April 14, 2018
How should HIV resources be allocated? Lessons learnt from applying Optima HIV in 23 countries
Robyn M Stuart, Laura Grobicki, Hassan Haghparast-Bidgoli, et al.
Communications Medicine
|
May 23, 2022
Impact of SARS-CoV-2 Gamma lineage introduction and COVID-19 vaccination on the epidemiological landscape of a Brazilian city
Cecília Artico Banho, Lívia Sacchetto, Guilherme Rodrigues Fernandes Campos, et al.
The Lancet. Global Health
|
August 9, 2014
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models
Jeffrey W Eaton, Nicolas A Menzies, John Stover, et al.
The Lancet. Global Health
|
August 2, 2014
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models
Jeffrey W Eaton, Nicolas A Menzies, John Stover, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 11, 2020
COVID-19 reopening strategies at the county level in the face of uncertainty: Multiple Models for Outbreak Decision Support
Katriona Shea, Rebecca K Borchering, William J M Probert, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
The Lancet. Global Health
|
April 15, 2021
Estimating and mitigating the risk of COVID-19 epidemic rebound associated with reopening of international borders in Vietnam: a modelling study
Quang D Pham, Robyn M Stuart, Thuong V Nguyen, et al.
Plos One
|
October 4, 2017
Getting it right when budgets are tight: Using optimal expansion pathways to prioritize responses to concentrated and mixed HIV epidemics
Robyn M Stuart, Cliff C Kerr, Hassan Haghparast-Bidgoli, et al.
The Lancet. HIV
|
March 16, 2018
The global Optima HIV allocative efficiency model: targeting resources in efforts to end AIDS
Sherrie L Kelly, Rowan Martin-Hughes, Robyn M Stuart, et al.
Plos Computational Biology
|
July 26, 2021
Covasim: An agent-based model of COVID-19 dynamics and interventions
Cliff C Kerr, Robyn M Stuart, Dina Mistry, et al.
Plos Computational Biology
|
September 27, 2021
Optima TB: A tool to help optimally allocate tuberculosis spending
Lara Goscé, Gerard J Abou Jaoude, David J Kedziora, et al.
Journal of the International AIDS Society
|
April 14, 2018
How should HIV resources be allocated? Lessons learnt from applying Optima HIV in 23 countries
Robyn M Stuart, Laura Grobicki, Hassan Haghparast-Bidgoli, et al.
Communications Medicine
|
May 23, 2022
Impact of SARS-CoV-2 Gamma lineage introduction and COVID-19 vaccination on the epidemiological landscape of a Brazilian city
Cecília Artico Banho, Lívia Sacchetto, Guilherme Rodrigues Fernandes Campos, et al.
The Lancet. Global Health
|
August 9, 2014
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models
Jeffrey W Eaton, Nicolas A Menzies, John Stover, et al.
The Lancet. Global Health
|
August 2, 2014
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models
Jeffrey W Eaton, Nicolas A Menzies, John Stover, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 11, 2020
COVID-19 reopening strategies at the county level in the face of uncertainty: Multiple Models for Outbreak Decision Support
Katriona Shea, Rebecca K Borchering, William J M Probert, et al.
Page
of 7